Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1325 of 2228 entries
View as:

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02489968 Org: User:
Start: 05/12/15 End: 06/16/17 Due: 06/16/18

Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02182076 Org: User:
Start: 10/31/05 End: - Due: -

LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01015118 Org: User:
Start: 11/17/09 End: 09/15/16 Due: 09/15/17

Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259920 Org: User:
Start: 12/31/03 End: - Due: -

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia

Phase: N/A Priority: Normal
NCT ID: NCT04424290 Org: User:
Start: 06/12/20 End: 04/28/23 Due: 04/28/24

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01422876 Org: User:
Start: 08/31/11 End: 09/30/13 Due: 09/30/14

A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05182840 Org: User:
Start: 01/11/22 End: 07/10/23 Due: 07/10/24

A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems

Phase: N/A Priority: Normal
NCT ID: NCT05718648 Org: User:
Start: 02/09/23 End: 08/15/23 Due: 08/15/24

A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01205373 Org: User:
Start: 09/30/10 End: - Due: -

Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT03710824 Org: User:
Start: 02/28/19 End: 02/22/23 Due: 02/22/24

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Phase: N/A Priority: Normal
NCT ID: NCT00273962 Org: User:
Start: 05/31/02 End: 11/30/03 Due: 11/30/04

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00274547 Org: User:
Start: 09/30/01 End: - Due: -

Ibuprofen/Caffeine Lower Back or Neck Pain Study

Phase: N/A Priority: Normal
NCT ID: NCT03003000 Org: User:
Start: 12/20/16 End: 09/28/17 Due: 09/28/18

Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02261103 Org: User:
Start: 04/30/06 End: - Due: -

Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02215746 Org: User:
Start: 01/31/08 End: - Due: -

Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02171832 Org: User:
Start: 07/31/09 End: - Due: -

Relative Bioavailability of Empagliflozin (BI 10773) (Final Formulation) Compared to Empagliflozin (BI 10773 XX) (Trial Formulation 2) in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01242176 Org: User:
Start: 11/30/10 End: - Due: -

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Phase: N/A Priority: Normal
NCT ID: NCT02262611 Org: User:
Start: 01/31/03 End: - Due: -

Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00309608 Org: User:
Start: 04/30/06 End: - Due: -

Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00076999 Org: User:
Start: 11/30/03 End: - Due: -

A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04679948 Org: User:
Start: 12/21/20 End: 03/17/21 Due: 03/17/22

Drug Interaction Study of Digoxin and BI 10773

Phase: N/A Priority: Normal
NCT ID: NCT01306175 Org: User:
Start: 02/28/11 End: - Due: -

Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02172456 Org: User:
Start: 05/31/02 End: - Due: -

Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00932646 Org: User:
Start: 06/30/09 End: - Due: -

Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02276378 Org: User:
Start: 07/31/08 End: - Due: -